Relationship Between Symptoms of Temporomandibular Disorders and Estrogen Levels in Women with Different Menstrual Status

Aims: To evaluate whether serum estrogen level is associated with chronic pain, masticatory dysfunction, and depressive symptoms and/or somatization in women with temporomandibular disorders (TMD) and different menstrual cycle status. Methods: A total of 64 women were allocated into one of three groups: one composed of women with normal menstrual cycles (Group 1), one composed of pregnant women (Group 2), and one composed of women in surgical menopause (Group 3). All respondents underwent a standardized clinical examination with the Research Diagnostic Criteria for TMD (RDC/TMD). Diagnoses were generated according to Axis I, and grades of chronic pain, depressive symptoms, and somatization were evaluated according to Axis II. The level of serum estradiol was measured by using the immunofluorescent method. Analysis of variance, Kruskal-Wallis test with post hoc comparisons via series of Mann-Whitney U tests, and Spearman correlation coefficient were used for comparisons between study participants. Results: Reported pain was decreased with the progress of pregnancy among the women from Group 2 and was the lowest at the 36th week of pregnancy. Women in surgical menopause reported higher pain intensity as well as more difficulties with chewing and eating hard and soft food compared to the other subjects. Depressive symptoms and somatization were lowest among the women with advanced pregnancy and the highest among menopausal women. Conclusion: TMD-related chronic pain grade, masticatory dysfunction, and depressive symptoms and somatization are the highest when the estrogen level is the lowest.

chronic pain;estrogen;menstrual status;surgical menopause;temporomandibular disorders

1.Furquim BD, Flamengui LM, Conti PC. TMD and chronic pain: A current view. Dental Press J Orthod 2015;20:127–133.

2.Romero-Reyes M, Uyanik JM. Orofacial pain management: Current perspectives. J Pain Res 2014;7:99–115.

3.Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research Diagnostic Criteria for Temporomandibular Disorders: A systematic review of Axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:453–462.

4.Patil SR, Yadav N, Mousa MA, et al. Role of female reproduc-tive hormones estrogen and progesterone in temporomandib-ular disorder in female patients. J Oral Res Rev 2015;7:41–43.

5.LeResche L. Epidemiology of temporomandibular disorders: Implications for the investigation of etiologic factors. Crit Rev Oral Biol Med 1997;8:291–305.

6.LeResche L, Dworkin SF, Saunders K, Von Korff M, Barlow W. Is postmenopausal hormone use a risk factor for TMD? (ab-stract 675). J Dent Res 1994;73:186.

7.Berger M, Szalewski L, Bakalczuk M, Bakalczuk G, Bakalczuk S, Szkutnik J. Association between estrogen levels and tem-poromandibular disorders: A systematic literature review. Prz Menopauzalny 2015;14:260–270.

8.Puri J, Hutchins B, Bellinger LL, Kramer PR. Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint. Reprod Biol Endocrinol 2009;7:155.

9.Cheng P, Ma X, Li S. Histologic study of the temporomandibu-lar joints after ovariectomy in rats [in Chinese]. Zhonghua Kou Qiang Yi Xue Za Zhi 2000;35:458–461.

10.Papka RE, Srinivasan B, Miller KE, Hayashi S. Localization of estrogen receptor protein and estrogen receptor mes-senger RNA in peripheral autonomic and sensory neurons. Neuroscience 1997;79:1153–1163.

11.Cairns BE, Sessle BJ, Hu JW. Characteristics of glutamate-evoked temporomandibular joint afferent activity in the rat. J Neurophysiol 2001;85:2446–2454.

12.Cairns BE, Sessle BJ, Hu JW. Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles. J Neurosci 1998;18:8056–8064.

13.Cairns BE, Sim Y, Bereiter DA, Sessle BJ, Hu JW. Influence of sex on reflex jaw muscle activity evoked from the rat temporo-mandibular joint. Brain Res 2002;957:338–344.

14.Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson P. Sex-related differences in human pain and rat afferent dis-charge evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2001;86:782–791.

15.Dong XD, Mann MK, Kumar U, et al. Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge re-sult from estrogen-mediated modulation of peripheral NMDA receptor activity. Neuroscience 2007;146:822–832.

16.Dao TT, Knight K, Ton-That V. Modulation of myofascial pain by the reproductive hormones: A preliminary report. J Prosthet Dent 1998;79:663–670.

17.LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 2003;106:253–261.

18.Isselée H, De Laat A, De Mot B, Lysens R. Pressure-pain threshold variation in temporomandibular disorder myalgia over the course of the menstrual cycle. J Orofac Pain 2002;16: 105–117.

19.Wise EA, Riley JL 3rd, Robinson ME. Clinical pain perception and hormone replacement therapy in postmenopausal women experiencing orofacial pain. Clin J Pain 2000;16:121–126.

20.Hassan S, Muere A, Einstein G. Ovarian hormones and chron-ic pain: A comprehensive review. Pain 2014;155:2448–2460.

21.Vilanova LS, Gonçalves TM, Meirelles L, Garcia RC. Hormonal fluctuations intensify temporomandibular dis-order pain without impairing masticatory function. Int J Prosthodont 2015;28:72–74.

22.Dworkin SF, LeResche L. Research diagnostic criteria for tem-poromandibular disorders. J Craniomandib Disord 1992;6: 301–355.

23.Derogatis LR. SCL-90. Administration, Scoring, and Procedures Manual for the R (evised) Version and Other Instruments of the Psychopathology Rating Scale Series. Baltimore: Johns Hopkins, 1977.

24.LeResche L, Sherman JJ, Huggins K, et al. Musculoskeletal orofacial pain and other signs and symptoms of temporo-mandibular disorders during pregnancy: A prospective study. J Orofac Pain 2005;19:193–201.

25.Sherman JJ, LeResche L, Mancl LA, Huggins K, Sage JC, Dworkin SF. Cyclic effects on experimental pain response in women with temporomandibular disorders. J Orofac Pain 2005;19:133–143.

26.Landi N, Manfredini D, Lombardi I, Casarosa E, Bosco M. 17- beta-estradiol and progesterone serum levels in temporo-mandibular disorder patients. Minerva Stomatol 2004;53: 651–660.

27.Landi N, Lombardi I, Manfredini D, et al. Sexual hormone serum levels and temporomandibular disorders. A preliminary study. Gynecol Endocrinol 2005;20:99–103.

28.Kapila S, Wang W, Uston K. Matrix metalloproteinase induction by relaxin causes cartilage matrix degradation in target synovial joints: Receptor profiles correlate with matrix turnover. Annals of the New York Academy of Sciences 2009;1160:322–328.

29.Kapila S, Xie Y. Targeted induction of collagenase and strome-lysin by relaxin in unprimed and beta-estradiol-primed diarthro-dial joint fibrocartilaginous cells but not in synoviocytes. Lab Invest 1998;78:925–938.

30.Takeuchi S, Mukai N, Tateishi T, Miyakawa S. Production of sex steroid hormones from DHEA in articular chondrocyte of rats. Am J Physiol Endocrinol Metab 2007;293:E410–E415.

31.Yu SB, Wang MQ, Zhao W, Cao HT, Liu YL. The effects of age and sex on the expression of aromatase in the rat temporoman-dibular joint. J Orofac Pain 2006;20:156–165.

32.Vrahas MS, Mithoefer K, Joseph D. The long-term effects of articular impaction. Clin Orthop Relat Res 2004;(423):40–43.

33.Bijlsma JWJ, da silva JAP. EULAR Textbook on Rheumatic Diseases. London: BMJ Group, 2012.

34.Chisnoiu AM, Picos AM, Popa S, et al. Factors involved in the etiology of temporomandibular disorders—A literature review. Clujul Med 2015;88:473–478.

35.Ferrando M, Andreu Y, Galdón MJ, Durá E, Poveda R, Bagán JV. Psychological variables and temporomandibular disorders: Distress, coping, and personality. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:153–160.

36.Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of es-tradiol through endogenous opioid neurotransmission in wom-en. J Neurosci 2006;26:5777–5785.

37.Soares CN, Poitras JR, Prouty J. Effect of reproductive hor-mones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 2003;20:85–100.

38.Su Q, Cheng Y, Jin K, et al. Estrogen therapy increases BDNF expression and improves post-stroke depression in ovariecto-my-treated rats. Exp Ther Med 2016;12:1843–1848.

39.Nekora-Azak A. Temporomandibular disorders in relation to female reproductive hormones: A literature review. J Prosthet Dent 2004;91:491–493.

40.Craft RM. Modulation of pain by estrogens. Pain 2007; 132(suppl):S3–S12.

41.Kellesarian SV, Al-Kheraif AA, Vohra F, et al. Cytokine profile in the synovial fluid of patients with temporomandibular joint disorders: A systematic review. Cytokine 2016;77:98–106.

42.Teixeira JM, Bobinski F, Parada CA, Sluka KA, Tambeli CH. P2X3 and P2X2/3 receptors play a crucial role in articular hyperalgesia development through inflammatory mechanisms in the knee joint experimental synovitis. Mol Neurobiol 2017; 54:6174–6186.

43.Alstergren P, Kopp S. Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory dis-orders. J Oral Maxillofac Surg 2000;58:180–186.

44.Zhang P, Gan YH. Prostaglandin E2 upregulated trigeminal ganglionic sodium channel 1.7 involving temporomandib-ular joint inflammatory pain in rats. Inflammation 2017;40: 1102–1109.

45.Rodrigues L, Oliveira MC, Pelegrini-da-Silva A, de Arruda Veiga MC, Parada CA, Tambeli CH. Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats. J Pain 2006;7:929–936.

46.Straub RH, Buttgereit F, Cutolo M. Benefit of pregnancy in in-flammatory arthritis. Ann Rheum Dis 2005;64:801–803.

47.Clemente JT, Parada CA, Veiga MC, Gear RW, Tambeli CH. Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint. Neurosci Lett 2004;372:250–255.

48.Okamoto K, Thompson R, Katagiri A, Bereiter DA. Estrogen status and psychophysical stress modify temporomandibular joint input to medullary dorsal horn neurons in a lamina-specif-ic manner in female rats. Pain 2013;154:1057–1064.

49.Lam DK, Sessle BJ, Hu JW. Glutamate and capsaicin effects on trigeminal nociception I: Activation and peripheral sensi-tization of deep craniofacial nociceptive afferents. Brain Res 2009;1251:130–139.

50.Flake NM, Bonebreak DB, Gold MS. Estrogen and inflamma-tion increase the excitability of rat temporomandibular joint af-ferent neurons. J Neurophysiol 2005;93:1585–1597.

51.Ribeiro-Dasilva MC, Peres Line SR, Leme Godoy dos Santos MC, et al. Estrogen receptor-alpha polymorphisms and predis-position to TMJ disorder. J Pain 2009;10:527–533.